FDA Grants Priority Review to Sevabertinib (BAY 2927088) for Treating HER2-Mutant Non-Small Cell Lung Cancer
Bayer’s Sevabertinib (BAY 2927088) Receives FDA Priority Review for HER2-Mutant Non-Small Cell Lung Cancer FDA Bayer has announced that its investigational compound, sevabertinib (BAY 2927088), has been granted Priority Review status by the U.S. Food and Drug Administration (FDA) for…
Pimicotinib Shows Leading Efficacy in Tenosynovial Giant Cell Tumor
Pimicotinib Shows Promising Phase 3 Results in Treating Tenosynovial Giant Cell Tumor (TGCT) Merck, a global leader in science and technology, has released detailed findings from Part 1 of its global Phase 3 MANEUVER trial. The study evaluated the investigational…
Wacker Biotech and Expression Manufacturing Partner to Boost Lentiviral Gene & Cell Therapy Development
Wacker Biotech US and Expression Manufacturing Forge Strategic Alliance to Accelerate Lentiviral Vector Development for Next-Generation Gene Therapies Wacker Biotech In an era marked by rapid advancements in gene and cell therapies, the demand for high-quality, scalable lentiviral vectors has…
Sonnenwagen Æthon – Prepared to Conquer the Ultimate Outback Challenge
Team Sonnenwagen Unveils “Æthon” — Aiming for Victory in the World’s Toughest Solar Race Sonnenwagen In front of an enthusiastic audience of 800 guests gathered in their hometown of Aachen, Team Sonnenwagen proudly unveiled their latest solar-powered race car, “Æthon.”…
PhosAgro and FAO Launch RECSOIL Workshops on Soil Recarbonization
PhosAgro and FAO Launch RECSOIL Workshops on Soil Recarbonization PhosAgro, a leading Russian producer of phosphate-based fertilizers, in collaboration with the United Nations Food and Agriculture Organization (FAO), has initiated a series of scientific and practical workshops focusing on soil…
AskBio Publishes Full Phase 1b Results for AB-1005 Gene Therapy in Parkinson’s
AskBio Publishes Full Phase 1b Results for AB-1005 Gene Therapy in Parkinson’s AskBio a pioneering gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has recently announced the full publication of the results from its…
PPG Named to Newsweek’s 2025 Greenest Companies List
PPG Recognized Among Newsweek’s World’s Greenest Companies 2025: A Deep Dive into Its Sustainability Progress and Commitment PPG a global leader in paints, coatings, and specialty materials, has been named to Newsweek magazine’s “World’s Greenest Companies 2025” list. The recognition…
Perma-Pipe International Secures New Project Contract in Qatar
Perma-Pipe International Holdings Announces First Major Contract in Qatar, Marking a Strategic Expansion into the Gulf Region Perma-Pipe International Holdings, a leading global provider of pre-insulated piping systems and leak detection technologies, has officially announced a major milestone in its…
Specialty Carbon Black Market Forecast 2025–2034: Key Trends & Insights
Global Specialty Carbon Black Market Forecast (2025–2034): Trends, Segmentation, and Strategic Insights The global specialty carbon black market is poised for significant growth between 2025 and 2034, driven by its expanding role in high-performance applications across industries such as plastics,…
Mitsui Chemicals Unveils New Corporate Venture Capital Fund, ‘321Catalyst™
Mitsui Chemicals Launches $60 Million Corporate Venture Capital Fund ‘321Catalyst™’ to Drive Global Innovation and Strategic Growth Mitsui Chemicals, a leading global chemical manufacturer headquartered in Japan, has announced the official launch of its second corporate venture capital (CVC) fund,…
ASC25 Student Supercomputer Challenge: Shanghai Jiao Tong Wins Gold, Peking University Takes Silver
Tong Wins Gold Shanghai Jiao Tong University Triumphs at ASC25 Student Supercomputer Challenge; Peking University Secures Silver The 2025 ASC Student Supercomputer Challenge (ASC25) concluded successfully at Qinghai University in Xining, China, marking a significant milestone in the realm of…
EU Recommends Approval of Eylea™ 8 mg with Extended 6-Month Dosing Interval
Bayer’s Eylea™ 8 mg Receives EMA Recommendation for Extended 6-Month Dosing Interval in Europe Bayer has announced that the Eylea™ 8 mg Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive…